Sum up, high-dose VC may potentially result in inhibition of the PI3K/AKT/mTOR pathway in sepsis, reducing myocardial apoptotic damage and inflammatory storm, increasing autophagy, and ultimately protecting the myocardium. The gene discussed is AKT1; the disease is Sepsis.